Effect of Enteral Docosahexaenoic Acid Administration in Children With Acute Lymphoblastic Leukemia (DHA-ALL)
The Effect of Enteral Administration of Polyunsaturated Omega-3 Fatty Acids on Nutritional Status; the Treatment Toxicity and Early Mortality in Children With Acute Lymphoblastic Leukemia - a Controlled Study
Sponsor: Coordinación de Investigación en Salud, Mexico
Listed as NCT01051154, this PHASE2 trial focuses on Acute Lymphoblastic Leukemia and Malnutrition and remains completed. Sponsored by Coordinación de Investigación en Salud, Mexico, it has been updated 7 times since 2010, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE2
First recorded
Sep 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Coordinación de Investigación en Salud, Mexico
- Instituto Mexicano del Seguro Social
- National Council of Science and Technology, Mexico
For direct contact, visit the study record on ClinicalTrials.gov .